作者: Elisabetta Vegeto , George F. Allan , William T. Schrader , Ming-Jer Tsai , Donald P. McDonnell
DOI: 10.1016/0092-8674(92)90234-4
关键词: Biology 、 Binding domain 、 Receptor transactivation 、 Progesterone receptor 、 Interleukin-21 receptor 、 Agonist 、 Antagonism 、 Cell biology 、 Enzyme-linked receptor 、 Biochemistry 、 Receptor 、 General Biochemistry, Genetics and Molecular Biology
摘要: Abstract The human progesterone receptor form B (hPR-B) was expressed in Saccharomyces cerevisiae together with a specific reporter plasmid. To understand the mechanism underlying antagonist ligand activity, libraries of hormone binding domain (HBD)-mutated hPR-B molecules were prepared. A mutant identified that had lost ability to bind either or R5020; it could still RU486 and, surprisingly, fully activated transcription presence this "antagonist" and other antiprogestins. When assayed mammalian cells, again demonstrated agonistic activity. Sequence analysis indicated phenotype due truncation carboxy (C)-terminal 42 aa. We conclude amino acids extreme C-terminal region are required for progesterone, while antagonists site located more N-terminal HBD. Our results suggest contains an inhibitory function silences transactivation absence agonist antagonist.